Nazione: Svizzera
Lingua: tedesco
Fonte: Swissmedic (Swiss Agency for Therapeutic Products)
glofitamabum
Roche Pharma (Schweiz) AG
L01FX
glofitamabum
Konzentrat zur Herstellung einer Infusionslösung
glofitamabum 10 mg, histidinum, histidini hydrochloridum monohydricum, methioninum, saccharum, polysorbatum 20, aqua ad iniectabile, q.s. ad solutionem pro 10 ml.
A
Biotechnologika
diffuses grosszelliges B-Zell Lymphom
befristet
2023-07-11